• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov6
Zevra Therapeutics released FY2025 9 Months Earnings on November 5 After-Market EST, with actual revenue of USD 72.35 M and EPS of USD 1.1427
00:00
Zevra Therapeutics released FY2025 Q3 earnings on November 5 After-Market EST, actual revenue USD 26.06 M (forecast USD 26.64 M), actual EPS USD -0.01 (forecast USD -0.0337)
00:00
Oct29
Zevra Therapeutics to release FY2025 Q3 earnings on November 5 After-Market EST, forecast revenue USD 26.64 M, EPS USD -0.0337
00:48
Oct10
Zevra Therapeutics CEO Reports Disposition of Common Stock
23:18
Aug12
Zevra Therapeutics released FY2025 Semi-Annual earnings on August 12 After-Market EST, actual revenue USD 46.28 M, actual EPS USD 1.16
23:00
Zevra Therapeutics released FY2025 Q2 earnings on August 12 After-Market (EST), actual revenue USD 25.88 M (forecast USD 22.49 M), actual EPS USD 1.2343 (forecast USD 1.6125)
23:00

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 26.06 M, Net Income -544 K, EPS -0.01

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 25.88 M, Net Income 69.4 M, EPS 1.2343

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 20.4 M, Net Income -3.099 M, EPS -0.0572

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
AFJK
88.500
+1,006.25%
+80.500
OCG
10.270
+291.98%
+7.650
NCPL
1.400
+112.48%
+0.741
LGHL
8.050
+85.91%
+3.720
JXG
8.630
+67.90%
+3.490
ATMVR
1.060
+49.49%
+0.351
DBI
7.200
+48.45%
+2.350
HSPO
17.500
+42.28%
+5.200
CYPH
1.620
+39.66%
+0.460
ALEX
20.850
+37.71%
+5.710
View More